Earnings Call · Q1 FY2022·2022-05-05

Q1 22EPS -46.67%·Rev n/aQ4 21EPS -33.33%·Rev n/aQ3 21EPS -23.53%·Rev n/aQ2 21EPS -38.46%·Rev n/a⚠ consensus missing

Bionano Genomics, Inc. BNGO

Amy Conrad — Investor Relations

Erik Holmlin — Chief Executive Officer

Chris Stewart — Chief Financial Officer

−7.1%1d on move date−6.5% vs SPY3d−16.1%5d−16.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BNGO calls or request research access.

More BNGO calls Browse calls Request research access